ID

37684

Descrição

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT01788189

Link

https://clinicaltrials.gov/show/NCT01788189

Palavras-chave

Versões (2)
  1. 16/08/2019 16/08/2019 -
  2. 16/08/2019 16/08/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

16 de agosto de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility B-cell Lymphoma NCT01788189

Inglês

Eligibility B-cell Lymphoma NCT01788189

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥ 18 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
performance status ecog 0 - 3
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
first or subsequent relapse or refractoriness of a biopsy-proven cd20-positive aggressive b cell lymphoma (excluding mantle cell lymphoma)
Descrição

Recurrent Aggressive Adult Non-Hodgkin Lymphoma B-Cell CD20 positive | Non-Hodgkin's lymphoma aggressive refractory B-Cell CD20 positive | Exception Mantle cell lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0677726
UMLS CUI [1,2]
C0004561
UMLS CUI [1,3]
C3888518
UMLS CUI [2,1]
C0854870
UMLS CUI [2,2]
C0004561
UMLS CUI [2,3]
C3888518
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0334634
measurable disease
Descrição

Measurable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
ineligibility or unwillingness to undergo high-dose chemotherapy with autologous stem cell transplantation
Descrição

Ineligibility High-Dose Chemotherapy with Autologous Stem Cell Transplant | High-Dose Chemotherapy with Autologous Stem Cell Transplant Unwilling

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C1512429
UMLS CUI [2,1]
C1512429
UMLS CUI [2,2]
C0558080
ability to understand the aim of the study and act accordingly
Descrição

Comprehension Study Protocol | Protocol Compliance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0525058
effective contraception
Descrição

Contraceptive methods

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0700589
signed informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
central nervous system relapse of aggressive lymphoma
Descrição

Central nervous system lymphoma Aggressive Relapse

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0280803
UMLS CUI [1,2]
C0580822
UMLS CUI [1,3]
C0205336
any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study
Descrição

Medical condition Study Subject Participation Status Excluded | Laboratory test result abnormal Study Subject Participation Status Excluded | Mental disorder Study Subject Participation Status Excluded

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0332196
UMLS CUI [2,1]
C0438215
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C0332196
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C2348568
UMLS CUI [3,3]
C0332196
any condition including the presence of laboratory abnormalities which places the subject at unacceptable risk if he/she were to participate in the study
Descrição

Condition Study Subject Participation Status At risk | Laboratory test result abnormal Study Subject Participation Status At risk

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1444641
UMLS CUI [2,1]
C0438215
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C1444641
any condition that confounds the ability to interpret data from the study
Descrição

Condition Interferes with Interpretation Research data

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0459471
UMLS CUI [1,4]
C0681873
inadequate organ function not related to aggressive lymphoma:
Descrição

Organ function Inadequate | Relationship Absent Aggressive Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205412
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C1332225
neutrophils < 1.0/nl
Descrição

Neutrophil count

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0200633
platelets < 75/nl
Descrição

Platelet Count measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032181
creatinine clearance < 60 ml/min
Descrição

Creatinine clearance measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0373595
bilirubin ≥ 2,5 mg/dl
Descrição

Bilirubin measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0344395
serum ast/got or alt/gpt ≥ 4 x upper limit of normal
Descrição

Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
active viral hepatitis (hbv, hcv), hiv infection, any other uncontrolled infection
Descrição

Viral hepatitis | Hepatitis B | Hepatitis C | HIV Infection | Communicable Disease Uncontrolled

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0042721
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
UMLS CUI [4]
C0019693
UMLS CUI [5,1]
C0009450
UMLS CUI [5,2]
C0205318
pregnancy and nursing period
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Voltar ao início da página

Similar models

Eligibility B-cell Lymphoma NCT01788189

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
performance status ecog 0 - 3
boolean
C1520224 (UMLS CUI [1])
Recurrent Aggressive Adult Non-Hodgkin Lymphoma B-Cell CD20 positive | Non-Hodgkin's lymphoma aggressive refractory B-Cell CD20 positive | Exception Mantle cell lymphoma
Item
first or subsequent relapse or refractoriness of a biopsy-proven cd20-positive aggressive b cell lymphoma (excluding mantle cell lymphoma)
boolean
C0677726 (UMLS CUI [1,1])
C0004561 (UMLS CUI [1,2])
C3888518 (UMLS CUI [1,3])
C0854870 (UMLS CUI [2,1])
C0004561 (UMLS CUI [2,2])
C3888518 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0334634 (UMLS CUI [3,2])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Ineligibility High-Dose Chemotherapy with Autologous Stem Cell Transplant | High-Dose Chemotherapy with Autologous Stem Cell Transplant Unwilling
Item
ineligibility or unwillingness to undergo high-dose chemotherapy with autologous stem cell transplantation
boolean
C1512714 (UMLS CUI [1,1])
C1512429 (UMLS CUI [1,2])
C1512429 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Comprehension Study Protocol | Protocol Compliance
Item
ability to understand the aim of the study and act accordingly
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
Contraceptive methods
Item
effective contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lymphoma Aggressive Relapse
Item
central nervous system relapse of aggressive lymphoma
boolean
C0280803 (UMLS CUI [1,1])
C0580822 (UMLS CUI [1,2])
C0205336 (UMLS CUI [1,3])
Medical condition Study Subject Participation Status Excluded | Laboratory test result abnormal Study Subject Participation Status Excluded | Mental disorder Study Subject Participation Status Excluded
Item
any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study
boolean
C3843040 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0438215 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C0004936 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C0332196 (UMLS CUI [3,3])
Condition Study Subject Participation Status At risk | Laboratory test result abnormal Study Subject Participation Status At risk
Item
any condition including the presence of laboratory abnormalities which places the subject at unacceptable risk if he/she were to participate in the study
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0438215 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
Condition Interferes with Interpretation Research data
Item
any condition that confounds the ability to interpret data from the study
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0459471 (UMLS CUI [1,3])
C0681873 (UMLS CUI [1,4])
Organ function Inadequate | Relationship Absent Aggressive Lymphoma
Item
inadequate organ function not related to aggressive lymphoma:
boolean
C0678852 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0439849 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1332225 (UMLS CUI [2,3])
Neutrophil count
Item
neutrophils < 1.0/nl
boolean
C0200633 (UMLS CUI [1])
Platelet Count measurement
Item
platelets < 75/nl
boolean
C0032181 (UMLS CUI [1])
Creatinine clearance measurement
Item
creatinine clearance < 60 ml/min
boolean
C0373595 (UMLS CUI [1])
Bilirubin measurement
Item
bilirubin ≥ 2,5 mg/dl
boolean
C0344395 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
serum ast/got or alt/gpt ≥ 4 x upper limit of normal
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Viral hepatitis | Hepatitis B | Hepatitis C | HIV Infection | Communicable Disease Uncontrolled
Item
active viral hepatitis (hbv, hcv), hiv infection, any other uncontrolled infection
boolean
C0042721 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019693 (UMLS CUI [4])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Pregnancy | Breast Feeding
Item
pregnancy and nursing period
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial